Ann Arbor / Bergisch Gladbach / Osaka / Bristol / Pittsburgh / Wetzlar / Vancouver / Indianapolis / San Jose / Arlington / St. Louis / Santa Cruz / Denver / Shanghai / Minneapolis / Valencia / Vedbaek / Cologne / Beijing / Foster City / San Diego / Chicago / /
Japan / Canada / United Kingdom / China / Denmark / Germany / United States / / /
Event
FDA Phase / /
Facility
Institute of Medical Sciences / Institute of Health Sciences / Stem Cell Institute / Shanghai Renji Hospital / Key Laboratory of Stem Cell Biology / / /
IndustryTerm
the disease treatment / induction protocols / adherent differentiation protocol / cellular tool / chemical inhibitor / /
MedicalCondition
human glioblastoma cells / breast cancer / tumor / cancer / virus infection / Parkinson’s disease / diseases / neural degenerative diseases / infection / Disease / /
MedicalTreatment
cell therapy / chemotherapy / /
Organization
Key Laboratory of Stem Cell Biology / 3Shanghai Stem Cell Institute / Chinese Academy / Institute of Health Sciences / Shanghai JiaoTong University School of Medicine / Sciences / and Shanghai Jiao Tong University School / Chinese Academy of Sciences / Health Sciences and Shanghai Renji Hospital / Institute of Medical Sciences / /
Person
Duplex Oligonucleotides / Nicholas J. Cowan / Holm Zaehres / / /
Position
representative / China *Corresponding author / reporter / /